| Identification | Back Directory | [Name]
SB-423557 | [CAS]
351490-26-1 | [Synonyms]
SB-423557
SB423557,SB 423557
(R)-3-[4-Cyano-3-[2-hydroxy-3-(2-indan-2-yl-1,1-diMethylethylaMino)propoxy]phenyl]propionic acid ethyl ester
(R)-ethyl 3-(4-cyano-3-(3-((1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl)amino)-2-hydroxypropoxy)phenyl)propanoate
Benzenepropanoic acid, 4-cyano-3-[(2R)-3-[[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino]-2-hydroxypropoxy]-, ethyl ester | [Molecular Formula]
C28H36N2O4 | [MDL Number]
MFCD22665716 | [MOL File]
351490-26-1.mol | [Molecular Weight]
464.6 |
| Hazard Information | Back Directory | [Uses]
SB-423557 is an orally active calcium-sensing receptor (CaR) antagonist (IC50=520 nM), precursor of SB-423562 (IC50=73 nM). SB-423557 is well tolerated in human and increases plasma concentrations of exogenous parathyroid hormone (PTH) and stimulates bone formation[1]. | [in vivo]
SB-423557 (oral administration; 10, 30 or 100 μM/kg; once daily; 12 weeks) elicits transient increases in plasma concentrations of PTH, resulting in increased bone mass and strength in both vertebrae and long bones compared to that of OVX controls[1]. | [References]
[1] Kumar S, et al. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone. 2010 Feb;46(2):534-42. DOI:10.1016/j.bone.2009.09.028 |
|
| Company Name: |
Wuxi AppTec
|
| Tel: |
022-59987777 13552403979 |
| Website: |
www.labnetwork.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|